Author: Wang, Jun; Mei, Fanghua; Bai, Lu; Zhou, Suhua; Liu, Di; Yao, Lulu; Ahluwalia, Amrita; Ghiladi, Reza A.; Su, Lei; Shu, Tong; Gong, Miaozi; Wang, Xiaofang; Zhu, Lijun; Cai, Kun; Zhang, Xueji
Title: Serum nitrite and nitrate: A potential biomarker for post-covid-19 complications? Cord-id: 7o408jxr Document date: 2021_8_30
ID: 7o408jxr
Snippet: Nitric oxide (NO) plays an important role in cardiovascular and immune systems. Quantification of blood nitrite and nitrate, two relatively stable metabolites of NO (generally as NO(x)), has been acknowledged representing NO bioactivity partially. Dysregulation of NO(x) had been reported in SARS-CoV-2 infected populations, but whether patients recovered from COVID-19 disease present with restored NO(x) is unknown. In this study, serum NO(2)(−) and NO(3)(−) were quantified and analyzed among
Document: Nitric oxide (NO) plays an important role in cardiovascular and immune systems. Quantification of blood nitrite and nitrate, two relatively stable metabolites of NO (generally as NO(x)), has been acknowledged representing NO bioactivity partially. Dysregulation of NO(x) had been reported in SARS-CoV-2 infected populations, but whether patients recovered from COVID-19 disease present with restored NO(x) is unknown. In this study, serum NO(2)(−) and NO(3)(−) were quantified and analyzed among 109 recovered adults in comparison to a control group of 166 uninfected adults. Nitrite or nitrate levels were not significantly different among mild-, common-, severe- and critical-type patients. However, these recovered patients had dramatically lower NO(2)(−) and NO(2)(−)/NO(3)(−) than the uninfected group (p < 0.0001), with significantly higher NO(3)(−) levels (p = 0.0023) than the uninfected group. Nitrate and nitrite/nitrate were positively and negatively correlated with patient age, respectively, with age 65 being a turning point among recovered patients. These results indicate that low NO(2)(−), low NO(2)(−)/NO(3)(−) and high NO(3)(−) may be a potential biomarker of long-term poor or irreversible outcomes after SARS-CoV-2 infection. It suggests that NO metabolites might serve as a predictor to track the health status of recovered COVID-19 patients, highlighting the need to elucidate the role of NO after SARS-CoV-2 infection.
Search related documents:
Co phrase search for related documents- acidic neutral ph and acute respiratory syndrome: 1
- active site and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active site and additive effect: 1
- active site and low availability: 1
- active site and lung damage: 1
- acute exudative lesion and lung imaging: 1, 2, 3
- acute respiratory syndrome and additive effect: 1, 2, 3, 4, 5, 6, 7, 8
- acute respiratory syndrome and admission rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and long covid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and long term consequence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute respiratory syndrome and long term effect: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute respiratory syndrome and long term sequelae: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and low availability: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute respiratory syndrome and low significantly high: 1, 2, 3, 4, 5, 6, 7, 8
- acute respiratory syndrome and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and lung imaging: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- additive effect and long term effect: 1
- admission rate and lung damage: 1
- admission rate and lung imaging: 1
Co phrase search for related documents, hyperlinks ordered by date